An international, multicenter, randomized, double-blind phase III study of maintenance belagenpumatucel-l in non-small cell lung cancer (NSCLC): Updated analysis of patients enrolled within 12 weeks of completion of chemotherapy.-Reference-Cited by-同舟云学术

An international, multicenter, randomized, double-blind phase III study of maintenance belagenpumatucel-l in non-small cell lung cancer (NSCLC): Updated analysis of patients enrolled within 12 weeks of completion of chemotherapy.

Published:2014-05-20 Issue:15_suppl Volume:32 Page:8056-8056
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Bazhenova Lyudmila¹,Giaccone Giuseppe²,Nemunaitis John J.³,Juhász Erzsébet⁴,Ramlau Rodryg⁵,van den Heuvel Michel M⁶,Lal Rohit⁷,Dunlop David⁸,Garon Edward B.⁹,Chu Quincy S.¹⁰,Jain Minish Mahendra¹¹,Carrier Ewa¹²,Moses Steven¹²,Shawler Daniel¹²,Fakhrai Habib¹²

Affiliation:

1. UC San Diego Moores Cancer Center, La Jolla, CA

2. Georgetown University, Washington, formerly National Cancer Institute, Bethesda, MD

3. Mary Crowley Cancer Research Centers, Dallas, TX

4. Korányi National Institute for Pulmonology, Budapest, Hungary

5. Greater Poland Center for Pulmonary Diseases and Tuberculosis, Independent Public Health Care Center, Poznan, Poland

6. Netherlands Cancer Institute - Antonie van Leeuwenhoek hospital, Amsterdam, Netherlands

7. Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

8. Glasgow Royal Infirmary, Glasgow, United Kingdom

9. University of California, Los Angeles, Los Angeles, CA

10. Cross Cancer Centre, Edmonton, AB, Canada

11. Noble Hospital, Pune, India

12. NovaRx Corporation, San Diego, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.8056

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indirect comparison of efficacy and safety between immune checkpoint inhibitors and antiangiogenic therapy in advanced non–small-cell lung cancer;Scientific Reports;2018-06-26

2. The efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis;Scientific Reports;2016-08-25

3. Immunotherapy for lung cancer;Respirology;2016-04-21

4. Immunotherapy for non-small cell lung cancer: current concepts and clinical trials;European Journal of Cardio-Thoracic Surgery;2015-10-29

5. Vaccine immunotherapy in lung cancer: Clinical experience and future directions;Pharmacology & Therapeutics;2015-09